|
|
|
|
|
|
|
|
|
|
Previous: RETRACTABLE TECHNOLOGIES INC, 10QSB, EX-10.2, 2000-11-14 |
Next: HEMISPHERX BIOPHARMA INC, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 4,468,533
<SECURITIES> 0
<RECEIVABLES> 2,053,693
<ALLOWANCES> (10,351)
<INVENTORY> 938,517
<CURRENT-ASSETS> 7,829,721
<PP&E> 14,349,135
<DEPRECIATION> (3,249,644)
<TOTAL-ASSETS> 19,471,233
<CURRENT-LIABILITIES> (3,710,048)
<BONDS> 0
0
(9,268,245)
<COMMON> (1,002)
<OTHER-SE> (1,189,975)
<TOTAL-LIABILITY-AND-EQUITY> (19,471,233)
<SALES> (3,753,110)
<TOTAL-REVENUES> (3,753,110)
<CGS> 3,445,697
<TOTAL-COSTS> 2,972,876
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (2,507)
<INCOME-PRETAX> 2,662,956
<INCOME-TAX> 0
<INCOME-CONTINUING> 2,662,956
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 2,662,956
<EPS-BASIC> 0
<EPS-DILUTED> 0
</TABLE>
|
|